CD8A and Langer mesomelic dysplasia: In a study of patients with solid tumor malignancies and LMD receiving intravenous (IV) immune checkpoint inhibitors (ICIs), Prakadan et al. evaluated the CSF immune profiles before and after IV ICI treatment and found progressive CD8+ T cell abundance within the CSF9.